ClinConnect ClinConnect Logo
Search / Trial NCT05129345

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

Launched by DUKE UNIVERSITY · Nov 10, 2021

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Hypertension Dyslipidemias Type 2 Diabetes Hiv 1 Infection

ClinConnect Summary

This clinical trial is focused on improving the health of people living with HIV who also have conditions like high blood pressure, high cholesterol, or type 2 diabetes. The study has three main goals: first, to find out what social factors affect their health and identify what helps or hinders them from reaching their treatment goals; second, to evaluate how much knowledge and confidence these individuals have in managing their health conditions; and third, to create a support and education program that addresses the challenges they face, using input from various community members.

To join the study, participants need to be at least 35 years old and living with HIV, with at least one of the mentioned health conditions. The trial is open to all genders, and participants will be recruited from local clinics and community organizations. Those who take part can expect to share their experiences and help develop resources that could improve health management for themselves and others in similar situations. It’s important to note that individuals who don’t speak English or are blind will not be eligible to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aims 1 and 2
  • People living with HIV who are at least 35 years of age and who have one or more of the following conditions: hypertension, dyslipidemia, or type 2 diabetes.
  • Aim 3
  • Participants recruited from the participating clinics and community based organizations and may include, HIV providers, nurses, pharmacists, people living with HIV who have cardiometabolic disorders, and representatives of the community advisory boards, and any other key stakeholders. Age 18 or older.
  • Exclusion Criteria:
  • Those who don't understand English and those who are blind.

About Duke University

Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.

Locations

Charlotte, North Carolina, United States

Durham, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Charles Muiruri, PhD

Principal Investigator

Duke University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials